FDA Holds To Its Longstanding Interpretation Of Orphan Drug Exclusivity

By Beth Wang / January 23, 2023 at 5:49 PM
FDA on Monday (Jan. 23) announced that it will continue applying orphan drug exclusivity to indications or uses of a drug, rather than to entire diseases, despite a September 2021 appeals court ruling that said the law prevents FDA from approving a drug designated for the same rare disease or condition as a previously approved orphan drug even if the approvals are for separate indications or populations within the same disease. At the same time, the agency is rescinding its...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.